Fatigue in breast cancer patients on chemotherapy: a cross-sectional study exploring clinical, biological, and genetic factors

Table 1 Sociodemographic and baseline characteristics (N = 67)

		Frequency (%)
Gender	Female	67 (100%)
Nationality	Lebanese	60 (89.6%)
	Syrian	5 (7.5%)
	Other	2 (3%)
Marital status	Single	8 (11.9%)
	Married	58 (86.6%)
	Widowed	1 (1.5%)
Level of education^a	Elementary	9 (13.8%)
	Secondary	41 (63.1%)
	University	15 (23.1%)
Profession/Work	No	45 (67.2%)
	Yes	22 (32.8.%)
	Mean ± Standard Deviation (SD)
Age (years)	56.22 ± 11.96
Body Mass Index (BMI; Kg/m²)	26.06 ± 3.79
Body Surface Area (BSA; m²)	1.76 ± 0.17
Pain VAS score	1.27 ± 2.08
Fatigue Score	42.12 ± 32.10
▪ Fatigue > 39 (clinically significant fatigue)^b	31 (46.3%)
▪ Fatigue < 39 (no clinical fatigue)^b	36 (56.7%)
Sleep evaluation
Insomnia Severity Index (ISI) score	8.88 ± 6.35
Pittsburgh Sleep Quality Index (PSQI) score	8.20 ± 4.33
Psychological factors
HADS-A	7.18 ± 4.98
HADS-D	6.67 ± 4.41

^aSome variables did not sum up to 67 due to missing data
^bThe score of 39 is the defined thresholds for clinical importance (TCIs) for the EORTC QLQ-C30 Computer Adaptive Testing Core measure [52, 53]

ISSN: 1471-2407